A vaccine comprising retrovirus variants and live attenuated retrovirus
PK139904AUndetermined Publication Date: 2009-01-03GLAXOSMITHKLINE BIOLOGICALS SA
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200000737
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-01-03
Abstract
The invention provides an attenuated rotavirus population comprising single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. The invention particularly provides a rotavirus population designated as P43. The invention further provides a novel formulation for a rotavirus vaccine which is in the form of a quick dissolving tablet for immediate dissolution when placed on the tongue.
Need to check novelty before this filing date? Find Prior Art
